FdaApplication
ANDA 210416
Identifiers
- fda_app_no: ANDA210416
Properties
| Property | Value |
|---|---|
| applicant_name | DEVA HOLDING AS |
| application_type | ANDA |
| approval_date | 2023-12-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN; CLAVULANATE POTASSIUM | 400MG/5ML;EQ 57MG BASE/5ML | FOR SUSPENSION;ORAL |
1 product